SiSaf Ltd, a company developing RNA therapeutics for rare genetic skeletal disorders, is pleased to confirm that it will be presenting at and attending a number of upcoming business, partnering and scientific conferences, as detailed below.
/PRNewswire/ SiSaf Ltd, a company developing RNA therapeutics for rare genetic skeletal disorders, today announced that it has appointed Professor Michael J..
/PRNewswire/ SiSaf Ltd, a company developing RNA therapeutics for rare genetic skeletal disorders, today announced that it has appointed Professor Michael J..
/PRNewswire/ SiSaf Ltd, a company developing RNA therapeutics for rare genetic skeletal disorders, today announced that it has exercised its option under.